Link Silicon Valley
The fastest way to connect to the people, companies and capital of Silicon Valley
Free 30 Day Trial Account
Sign Up | Log In
My Lists

Genzyme  (Stock symbol: GENZ )

500 Kendall Street
Cambridge, MA 2142

Website Company Summary Management Team

Management: David Meeker (COO);  Sandford D Smith (President) Peter Wirth (Executive VP);  Henri Termeer (Chairman of the Board);  Michael Wyzga (CFO) Sue Dubman (Sr. Director, Standards and Architecture) Alan Smith (Chief Scientific Officer)
Former Management Team:  Aitung Liu Amy Tapper Jennifer Peppe John Neylan
Business Description

Genzyme Corporation (Genzyme) is a biotechnology company. The Company's product and service portfolio is focused on rare genetic disease disorders, renal diseases, orthopaedics, cancer, transplant and immune disease. Genzyme operates in four business segments: Genetic Diseases, Cardiometabolic and Renal, Biosurgery and Hematologic Oncology. Genetic Diseases unit develops, manufactures and distributes therapeutic products, with a focus on products to treat patients suffering from genetic diseases, including a family of diseases known as lysosomal storage disorders (LSDs). Cardiometabolic and Renal segment develops, manufactures and distributes products that treat patients suffering from renal diseases, including chronic renal failure and endocrine and cardiovascular diseases. Biosurgery develops, manufactures and distributes biotherapeutics and biomaterial-based products. Hematologic Oncology develops, manufactures and distributes products for the treatment of cancer.
Customer on 4  Companies

Investor on  1  Companies

Acquirer on  2  Companies

Last Tweets


Last Mentions

Record updated: Sep 2010
Ownership: Public  
Stock Symbol: GENZ